Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
NCT ID: NCT05486455
Last Updated: 2022-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2022-11-04
2028-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE
NCT05649046
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT05902559
Screening for Early Lung Cancer in Shanghai, China
NCT02185495
Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.
NCT06020443
Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer
NCT07042867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CT scan
Low-dose chest CT scan
baseline, 1-year, 3-year and 5-year low-dose CT scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-dose chest CT scan
baseline, 1-year, 3-year and 5-year low-dose CT scan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)
Exclusion Criteria
* Person unable to climb 2 floors
* Weight \> 140kg
* Personal history of cancer \< 5 years (currently being monitored by thoracic imaging)
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital St. Joseph, Marseille, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud Boyer, MD
Role: PRINCIPAL_INVESTIGATOR
Hopital Saint Joseph Marseille
Illies Bouabdallah, MD
Role: STUDY_DIRECTOR
Hopital Saint Joseph Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Saint Joseph
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEPITAB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.